![](/documents/10803/17046930/triple-negative-breast-cancer-new-hope-thumbnail.jpg/391c78e1-1248-c89f-90dd-4536db25ebb4?t=1721831057555)
Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...
![](/documents/10803/17046930/marathon-hope-cancer-centres-network-funding-thumbnail.jpg/872d8e02-6cf5-44b6-f548-2745ce52c536?t=1721753972996)
Prescribing personalized lifestyle interventions to improve prostate cancer treatments
David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...
![](/documents/10803/17046930/jabado-research-therapeutic-target-thumbnail.png/e83b6069-9a81-b257-f43d-0799fa333865?t=1720627005710)
Researchers find a possible therapeutic target in the “genetic landscape” of aggressive and deadly pediatric brain tumours
A new study reveals that PFA ependymoma brain tumours display...
![](/documents/10803/17046930/mcgill-collaborate-drug-discovery-thumbnail.jpg/82cfdfba-1c39-ec78-a2fe-5ab289c0fc7e?t=1720191903309)
McGill, industry, CQDM and Brain Canada collaborate for drug discovery
Novel drug could provide hope to those suffering from neuropathic pain and insomnia
![](/documents/10803/17046930/major-funding-awards-ri-trainees-thumbnail.png/2f14196b-7950-f83a-7363-4e7657b33521?t=1720020095337)
Major funding awards for seven RI-MUHC trainees
A Banting Fellowship and six Vanier Scholarships were awarded in 2024
![](/documents/10803/16967537/ri-researchers-precision-medicine-cancer-thumbnail.jpg/5a8fa6fa-77fb-ff4d-49ad-6287dafa008b?t=1718635866712)
RI-MUHC researchers work to accelerate precision medicine for cancer in Canada
Three additional RI-MUHC research projects funded by the Marathon of Hope Cancer Centres Network
![](/documents/10803/16967537/tech-fight-against-antimicrobial-resistance-thumbnail.jpg/932085bf-eab5-8fbb-5d7c-6df203503268?t=1718196484058)
Developing technology for fight against antimicrobial resistance
New treatment under development by researchers Karine Auclair and Andréanne Lupien could potentially treat intracellular infections without...
![](/documents/10803/16907235/annual-clinical-research-day-event-2024-thumbnail.jpg/ff5e0180-6d8e-c68f-f15e-e79bd7428d6d?t=1716901787516)
Annual Clinical Research Day event highlights RI-MUHC services and expertise in clinical trials
The Centre for Innovative Medicine and many other clinical research support teams introduced their skills...
![](/documents/10803/16907235/nada-jabado-l%27oreal-award-2024-thumbnail.jpg/f2e0f746-73f9-700e-00e3-d4f968c25188?t=1715706918089)
Nada Jabado named 2024 L’Oréal-UNESCO For Women in Science Laureate for North America
Prestigious award honours McGill and RI-MUHC pioneer in the field of pediatric brain tumours
![](/documents/10803/16844909/funding-marathon-hope-cancer-centres-network-thumbnail.jpg/84d4c7a1-3d6e-e7c1-892c-e190072389df?t=1714053453113)
Two RI-MUHC researchers receive funding from the Marathon of Hope Cancer Centres Network
Morag Park, Ph.D. and George Zogopoulos, MD., Ph.D., are two of the four beneficiaries of the Pan-Canadian...